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The highly studied p53 protein regulates multiple transitions

• Cancer remains as one of the most prevalent factors

1. Genetic Cloning – The wild type p53 gene was isolated

Comparisons were drawn between both DNMT1 and E2F1

and transformed into host E. coli plasmids awaiting

due to their cellular regulatory capabilities, nucleasomal

duplication.

presence, and elated tendencies for methyl transfers at

through the cell cycle effectively halting the growth of tumor-

determining the length and quality of human life.

like masses.[1] This gene was primitively identified an

• Exposure to carcinogens and UV radiation as well as the

oncogene; however, it was later derived that p53 functions

complications of the ageing human body are inevitable

2. Site-Directed Mutagenesis – The specific and intentional

lysine sites along their respective protein chains. Similar to

as a tumor suppressor.[1] Named due to its mass in kDa, p53

and often lead to cancerous tissue formations due to

placement of the mutation to the p53 gene altering the

p53K372, E2F1K185 is regulated by the epigenetic modifiers

is a phosphoprotein comprised of 393 amino acids.[1] Normal

abnormalities within the human body.

manifestational change to the protein’s primary sequence at

SET7/9

cells contain controlled, small quantities of p53 in order to

leucine (L) 369 to arginine (R) 369 was induced. An example

demethylated by LSD1.

facilitate the regulation of normal cell activities such as

of this process can be seen below:

and

LSD1.

Additionally,

DNMT1K142

is

growth arrest, senescence, DNA repair, and apoptosis.[1,2]
On one hand, when either LSD1 was inhibited or a siRNA
blocking the productions of LSD1 was introduced to proteins
E2F1 and DNMT1, the methylation of both proteins increased
which resulted in promoting the degradation pathways via E3
ubiquitin ligase proteolysis. On the other, the downregulation
These features are pivotal the continuation of healthy cell

of SET7/9 via siRNA eliminated methylation in the proteins

production. Constructively, the functions of p53 work together

altogether. Reduction of SET7/9 stabilized the proteins with or

to pause the cell growth cycles in order to address and repair

without the presence of LSD1. Dissimilarly, the stabilization of

certain sequences of DNA if needed before cell division

WT-p53 was not specifically linked to the interplay between

commences. If repair cannot be completed, then p53 signals

3. Transfection – Mutant L369R and wild type p53 were

LSD1 and SET7/9. We hypothesized that by mutating p53 at

for the cell to become senescent and/or later to destroy itself

inserted

leucine (L) 369 to arginine (R) that the mutant (L369R) can

via apoptosis.[1] Upon DNA damage and other cellular

reproduced in tissue cultures.

now be degraded by the E3 ubiquitin ligase due to the

stressors, the quantity of p53 is upregulated in order to

4. Western Blotting – As a check for proper transfection of

increased similarity of the proteasomal chain sequences of

both the mutant and wild type p53 proteins, the tissue cultures

the proteins. Results are yet to be concluded for this process.

into human 293T liver embryonic stem cells and

instigate either the repair or apoptotic cellular pathways;

• Cancers are a large family of diseases that involve

however, continued high levels of p53 are detrimental as its

abnormal cell growth possessing the potential to invade

were

increased ability to activate the apoptotic pathway is likened

other regions of the body through the formation of

separation. If the sample was the appropriate protein size,

to an accelerated aging process.[1]

neoplastic subsets.

further testing via attachment of specific antibodies came into

Furthering

play. The secondary specific antibody was always engineered

modifications on p53 will provide a wealth of knowledge not

to fluoresce resulting in evidence either for or against what

only of specific protein-protein interactions for the C-terminus

was expected. This process was repeated every time a

domain on the p53 protein but may lead to understanding

into pluripotent stem cells by Shinya Yamanaka, the

change in the experiment took place.

other nuclear proteins behaving in a similar manner. Hopefully,

question has arisen concerning the ability to influence

5. Small Interference RNA – Small sequences of RNA were

extending our knowledge of the p53 proteome and its

cancer stem cells in a similar manner.

deliberately manufactured in order to conduct experimental

correlating protein-protein interactions will unlock greater

disruptions to the general functionality of both the wild type

realizations for many other nuclear proteins of interest.

and mutated p53 proteomes. In doing so, the analysis of

Eventually, the idea will be to control cancer stem cells. This

the

several up- and downregulations leading to hopeful answers

power could lead to the descent of cancers as we know them.

patterns resulting in an array of dissimilar protein-protein

nucleosome have the ability to signal and direct a significant

to the questions concerning which pathways may be either

interactions thus greatly adding to the multiplicity of functions

amount of traffic in and around the nuclei of cells. These

extended or blocked in order to increase the control of cancer
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for the protein itself. This study aims to show that the control

changes directly affect the transcription of DNA chromatin.

stem cells and ultimately disenfranchise the bad cells and

of these modifications may not only reduce the causation of

• Tumor protein-53 is a dominant nuclear protein capable of

multiple forms of cancers but may also be used as a

multiple post-translational modifications. Understanding and

preventative mechanism by never allowing malignant masses

controlling tumor protein-53 will be paramount in this

to have formed in the first place.

strategy.

Modernizing the Approach
• Since the 2006 discovery of manipulating adult cells back

• The capability of reversing the effects of cancer would have
The C-terminus domain (CTD) of p53 contains several
modifiable lysine residues that may be augmented in different
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life-altering significance for medical treatment plans.
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